The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Advanced Multiparametric MRI of the Prostate (PI-RADS v2.1)

Combined T2, diffusion-weighted and dynamic contrast imaging for clinically significant prostate cancer detection.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Radyoloji department. Book Appointment →

What is Advanced Multiparametric MRI of the Prostate (PI-RADS v2.1)?

Multiparametric MRI (mpMRI) of the prostate combines high-resolution T2-weighted imaging, diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) maps and dynamic contrast-enhanced (DCE) sequences. PI-RADS v2.1 (Prostate Imaging Reporting and Data System) scores lesions from 1 (very low) to 5 (very high) probability of clinically significant cancer (Gleason >=3+4).

Indications include elevated PSA before biopsy (PRECISION, MRI-FIRST trials), active surveillance monitoring, biochemical recurrence after treatment and pre-prostatectomy staging. MRI-targeted biopsy (cognitive, ultrasound fusion or in-bore) detects more clinically significant cancers than systematic biopsy alone.

Bi-parametric MRI (bpMRI, T2 + DWI without contrast) is gaining acceptance for screening and active surveillance. Reporting requires standardized acquisition (3T preferred, endorectal coil optional), structured templates and certified radiologist expertise.

Symptoms

Persistently elevated PSA
Abnormal digital rectal examination
Active surveillance for low-risk prostate cancer
Biochemical recurrence after surgery or radiation
Pre-treatment staging of biopsy-confirmed cancer
Family history with rising PSA
Suspicious findings on transrectal ultrasound
Need to avoid or target prostate biopsy

Risk Factors

Age >50 years with elevated PSA
Family history of prostate cancer
BRCA1/BRCA2 mutation carrier
African ancestry
Prior negative biopsy with rising PSA
Active surveillance for known low-risk cancer
Biochemical recurrence after definitive therapy
Suspicious palpable nodule

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Elevated PSA above age-adjusted threshold
  • Abnormal digital rectal examination
  • Family history of prostate cancer with PSA increase
  • Active surveillance scheduled MRI follow-up
  • Rising PSA after prostatectomy or radiation
  • Pre-biopsy MRI evaluation

Treatment Methods

01
3T MRI scanner with surface coil (endorectal optional)
02
T2-weighted high-resolution imaging in three planes
03
Diffusion-weighted imaging with high b-values (>=1400 s/mm2)
04
Dynamic contrast-enhanced sequence with quantitative analysis
05
PI-RADS v2.1 structured reporting
06
MRI-targeted biopsy (cognitive, fusion or in-bore) for PI-RADS >=3
07
Multidisciplinary uro-oncology review
08
Periodic surveillance MRI on active monitoring

Which Department to Visit?

You can visit our Radyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Radyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.